1252780-50-9

Basic information

• Product Name: 3-fluoro-5-phenyl-benzo[b]thiophene-2-carboxylic acid
• Synonyms: 3-fluoro-5-phenyl-benzo[b]thiophene-2-carboxylic acid
• CAS NO: 1252780-50-9
• Molecular Weight: 272.3
• Mol File: 1252780-50-9.mol

Chemical Properties

• CAS DataBase Reference: 3-fluoro-5-phenyl-benzo[b]thiophene-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-fluoro-5-phenyl-benzo[b]thiophene-2-carboxylic acid(1252780-50-9)
• EPA Substance Registry System: 3-fluoro-5-phenyl-benzo[b]thiophene-2-carboxylic acid(1252780-50-9)

Safety Data

• Hazardous Substances Data: 1252780-50-9(Hazardous Substances Data)

Upstream product

• 1252780-49-6 5-phenylbenzo[b]thiophene-2-carboxylic acid 
• 98-80-6 phenylboronic acid 
• 154649-85-1 methyl 5-phenylbenzo[b]thiophene-2-carboxylate 
• 7312-11-0 5-bromo-1-benzothiophene-2-carboxylic acid methyl ester 

Downstream Products

• 1252781-80-8 3-fluoro-5-phenyl-benzo[b]thiophene-2-carbonyl chloride 
• 1373524-56-1 (3S)-N-{1-[(3-Fluoro-5-phenyl-1-benzothiophen-2-yl)carbonyl]azetidin-3-yl}-1-(phenylcarbonyl)pyrrolidin-3-amine 

Relevant articles and documents

OXOPIPERAZINE-AZETIDINE AMIDES AND OXODIAZEPINE-AZETIDINE AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS

Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (Ia) and Formula (Ib) as follows: wherein Y, Z, and n are defined herein; and wherein Yb and Zb are as defined herein.

AMINO-PYRROLIDINE-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS

Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula

DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS

Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows: wherein Q and Z are defined herein.